Preview

Current Pediatrics

Advanced search

Challenges of Timely Kawasaki Disease Diagnosis in 2-Month-Old Child: Clinical Case

https://doi.org/10.15690/vsp.v24i1.2856

Abstract

Background. Kawasaki disease is an acute febrile systemic vasculitis occurring primarily in children under the age of five years old. It is characterized by high risk of cardiovascular complications development, including coronary vessels aneurysm. Its timely diagnosis is difficult in the absence of major clinical signs.

Clinical case description. 2-month-old child developed a disease with the signs of respiratory infection, exanthema syndrome, severe anemia, thrombocytosis; he has laboratory signs of inflammation (leukocytosis, neutrophil shift, increased erythrocyte sedimentation rate and C-reactive protein level). The detection of early antibodies to cytomegalovirus infection and tick-borne borreliosis causative agent indicated the infectious nature of the disease. Clinical diagnosis was established: “Mixed infection: Lyme borreliosis, non-erythematous form, and unspecified serous meningitis, moderate severity, non-mild course. Prior disease complication: toxic-allergic dermatitis, secondary cardiopathy (toxic-infectious origin). Comorbid conditions: acquired cytomegalovirus infection, generalized form, with involvement of respiratory tract (nasopharyngotonsillitis), skin (exanthema syndrome), and hemopoietic system (severe anemia)”. The patient was transferred from somatic to infectious department, where he was administered with several courses of antibiotic therapy (ceftriaxone, cefepime, meropenem, vancomycin), antiviral drugs (viferon suppositories, acyclovir), RBC-transfusion was performed due to severe anemia. Single administration of human immunoglobulin was performed on the 18th day of the disease. The child was discharged with clinical recovery on the 35th day from the disease onset. Coronary artery aneurysm was revealed on the 30th day after discharge, retrospective diagnosis was established: Kawasaki disease.

Conclusion. Prolonged fever with nonspecific clinical manifestations of Kawasaki disease resulted in its late diagnosis. The disease was revealed only after the development of typical and at the same time severe complication — coronary artery aneurysm. Pediatricians should keep awareness on cases with long-term signs of inflammation with no established infectious disease.

About the Authors

Yuliya A. Ermolaeva
Siberian State Medical University
Russian Federation

Tomsk


Disclosure of interest:

Not declared.



Ivan R. Grishkevich
Siberian State Medical University
Russian Federation

Tomsk


Disclosure of interest:

Not declared.



Ivan V. Doroshenko
Siberian State Medical University
Russian Federation

Tomsk


Disclosure of interest:

Not declared.



Tatiana V. Zgerskaya
Children’s Infectious Diseases Hospital named after G.E. Sibirtseva
Russian Federation

Tomsk


Disclosure of interest:

Not declared.



Iuliia G. Samoilova
Siberian State Medical University
Russian Federation

Tomsk


Disclosure of interest:

Not declared.



Svetlana A. Gay
Children’s Infectious Diseases Hospital named after G.E. Sibirtseva
Russian Federation

Tomsk


Disclosure of interest:

Not declared.



Natalia A. Shmakova
Tomsk National Research Medical Center of the Russian Academy of Sciences
Russian Federation

Tomsk


Disclosure of interest:

Not declared.



References

1. Baranov АА, Namazova-Baranova LS, Tatochenko VK, et al. Review of Clinical Recommendations for Kawasaki Disease/Syndrome. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2017;14(2):87–99. (In Russ). doi: https://doi.org/10.15690/pf.v14i2.1723]

2. Kontopoulou T, Kontopoulos DG, Vaidakis E, Mousoulis GP. Adult Kawasaki disease in a European patient: a case report and review of the literature. J Med Case Rep. 2015;9:75. doi: https://doi.org/10.1186/s13256-015-0516-9

3. Makino N, Nakamura Y, Yashiro M, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol. 2015;25(3):239–245. doi: https://doi.org/10.2188/jea.JE20140089

4. Kawasaki Disease. In: Centers for Disease Control and Prevention: Official website. Available online: https://www.cdc.gov/kawasaki. Accessed on December 27, 2024.

5. Lin MC, Lai MS, Jan SL, et al. Epidemiologic features of Kawasaki disease in acute stages in Taiwan, 1997–2010: effect of different case definitions in claims data analysis. J Chin Med Assoc. 2015;78(2): 121–126. doi: https://doi.org/10.1016/j.jcma.2014.03.009

6. Bregel LV, Belozerov YuM, Subbotin VM, et al. Pediatria. Journal n.a. G.N. Speransky. 2011;90(5):49–53. (In Russ).]

7. Singh S, Jindal AK, Pilania RK. Diagnosis of Kawasaki disease. Int J Rheum Dis. 2018;21(1):36–44. doi: https://doi.org/10.1111/1756-185X.13224

8. Kuo HC. Diagnosis. progress, and treatment update of Kawasaki disease. Int J Mol Sci. 2023;24(18):13948. doi: https://doi.org/10.3390/ijms241813948

9. Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477–489. doi: https://doi.org/10.1038/s41577-019-0165-0

10. Bordea MA, Costache C, Grama A, et al. Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome. Physiol Res. 2022;71(1):17–27. doi: https://doi.org/10.33549/physiolres.934672

11. Slizisto-kozhnyi limfonodulyarnyi sindrom [Kavasaki] M30.3: Clinical guidelines. Union of Pediatricians of Russia. Ministry of Health of Russian Federation; 2016. 41 p. (In Russ).] Доступно по: https://www.consultant.ru/document/cons_doc_LAW_325962. Ссылка активна на: 12.12.2024.

12. Wessels PA, Bingler MA. A comparison of Kawasaki Disease and multisystem inflammatory syndrome in children. Prog Pediatr Cardiol. 2022;65:101516. doi: https://doi.org/10.1016/j.ppedcard.2022.101516

13. Tatochenko VK, Bakradze MD. Pediatru na kazhdyi den’ – 2022. Likhoradki: Reference book on diagnostics and treatment. Moscow: Federal State Autonomous Institution “National Medical Research Center of Children’s Health” of the Ministry of Health of the Russian Federation; 2022. 440 p.]

14. Noval Rivas M, Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol. 2020;16(7): 391–405. doi: https://doi.org/10.1038/s41584-020-0426-0

15. Zhu X, Zhou Q, Tong S, Zhou Y. Challenges and strategies in the management of coronary artery aneurysms. Hellenic J Cardiol. 2021;62(2):112–120. doi: https://doi.org/10.1016/j.hjc.2020.09.004

16. Thangathurai J, Kalashnikova M, Takahashi M, Shinbane JS. Coronary Artery Aneurysm in Kawasaki Disease: Coronary CT Angiography through the Lens of Pathophysiology and Differential Diagnosis. Radiol Cardiothorac Imaging. 2021;3(5):e200550. doi: https://doi.org/10.1148/ryct.2021200550

17. Singhal M, Pilania RK, Jindal AK, et al. Distal coronary artery abnormalities in Kawasaki disease: experience on CT coronary angiography in 176 children. Rheumatology (Oxford). 2023;62(2):815–823. doi: https://doi.org/10.1093rheumatology/keac217

18. Sokolovskaya VV, Litvinova AA, Krikova AV, Kozlov RS. Kawasaki syndrome in a young child: clinical case. Detskie Infektsii = Children’s Infections. 2023;22(4):63–68. (In Russ). doi: https://doi.org/10.22627/2072-8107-2023-22-4-63-68]

19. Zykov VV, Maltsev AE, Razin MP. Medicolegal and clinical aspects of Kawasaki syndrome diagnostics. Medical Newsletter of Vyatka. 2018;56(4):11–15. (In Russ).]


Review

For citations:


Ermolaeva Yu.A., Grishkevich I.R., Doroshenko I.V., Zgerskaya T.V., Samoilova I.G., Gay S.A., Shmakova N.A. Challenges of Timely Kawasaki Disease Diagnosis in 2-Month-Old Child: Clinical Case. Current Pediatrics. 2025;24(1):26-36. (In Russ.) https://doi.org/10.15690/vsp.v24i1.2856

Views: 363


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)